German drug containment and delivery company Schott Pharma has opened a new facility in Lukácsháza, Hungary.
It has been built for the production of high-quality prefillable glass syringes, with Schott “expanding its global capacities for strategically important high-value solutions that address key pharma trends.” Schott is also aiming to boost its presence in Europe.
Go deeper with GlobalData
The company broke ground on the facility in October 2022, and it took a year and a half to construct. It was funded by a total investment of €76m ($82m), with €9m of financial support coming from the local government. More than 120 new jobs will be supported by the facility.
Andreas Reisse, CEO of Schott Pharma, said: “With an increasing number of drugs being stored in prefillable glass syringes – from GLP-1 drugs to critical vaccines and innovative biologics, the manufacturing beginning at this site today will continue to support major trends in the pharma industry.”
Schott has production facilities in 14 countries, with the Lukácsháza site the second at which it manufactures glass syringes.
